Stock Taper
SCREENER COMPARE ANY 2 STOCKS
FLGT
FULGENT GENETICS, INC.
NASDAQ
$19.61
▼ DOWN 1.70% (-0.34)

KEY STATISTICS

Market Cap$556.94 M
52w High$31.04
52w Low$13.46
Dividend Yield—
Frequency—
P/E1961.00
Volume192.54K
Shares Out.28.40M

COMPANY

LEADERSHIP

Ming Hsieh
CHIEF EXECUTIVE
Ming Hsieh

COMPENSATION 2026

Salary$1,000,000
Stock Awards$4,000,000
Incentive Plan Pay$1,207,000
All Other Comp.$0
Total$6,207,000

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 29, 2016
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
1,315

PRICE TARGET

Target High$19.00
Target Low$19.00
Target Median$19.00
Target Consensus$19.00

UPCOMING EARNINGS

DateNov 6, 2026
DayFriday
Rev. Est.$86.30M
NOV
6
FRI

PRICE

$19.61 ▼ DOWN 1.70% (−$0.34)
$19.50$19.65$19.80$19.959:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM19.61

About Fulgent Genetics, Inc.

https://www.fulgentgenetics.com ↗

Fulgent Genetics provides comprehensive COVID-19, molecular, and genetic testing services—including oncology, carrier screening, and genome analysis—for healthcare providers, patients, and institutions worldwide.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT FULGENT GENETICS, INC. IS KNOWN FOR

KNOVA Prenatal Cell-Free DNA Screening
KNOVA Prenatal Cell-Free DNA Screening

Fulgent's non-invasive prenatal test (NIPT) screens for various fetal genetic conditions from a maternal blood sample, marking its strategic expansion into the comprehensive prenatal testing market.

COMPETITORS

COMPETITOR
DGX COMPARE
LH COMPARE
MYGN COMPARE
NTRA COMPARE

Revenue by Products

IconPRODUCTQ2-2025Q3-2025Q4-2025Q2-2026
Laboratory Services$81.8M $83.93M ▲$83.03M ▼$85.36M ▲

Revenue by Geography

MapREGIONQ2-2025Q3-2025Q4-2025Q2-2026
UNITED STATES$76.21M $77.61M ▲— $78.29M ▲
NonUS$5.6M $6.46M ▲$8.43M ▲$7.1M ▼
Other Countries$3.19M $3.33M ▲$3.67M ▲$4.04M ▲
CHINA$2.41M $3.13M ▲$4.76M ▲$3.08M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
95
LISTED HERE
21
RANKED BY POSITION SIZE
VTS.AX
0.00% · 551.8K
IWM
0.01% · 507.4K
FNDA
0.03% · 147.7K
DFMC
0.03% · 102.9K
XHS
0.73% · 79.0K
PRFZ
0.03% · 41.7K
SBIO
0.29% · 35.1K
AVSC
0.02% · 26.7K
XRSG.L
0.01% · 17.2K
JPSE
0.05% · 16.1K
GSSC
0.03% · 14.1K
GNOM
0.29% · 14.1K
SILX
2.07% · 9.5K
EES
0.02% · 7.1K
GERM
1.68% · 6.6K
MKTN
0.05% · 2.9K
URTY
0.00% · 785
NIFE
0.61% · 557
DM
DMRS
0.10% · 522
TMFX
0.02% · 396
FVI
0.03% · 110

INSTITUTIONAL OWNERSHIP

SHARES OWNED
80.91%
HOLDERS
265
TOP 12 OF 265 · RANKED BY POSITION SIZE
Ca Family Wealth, LLC
6.8M sh · $72.75M
Blackrock Inc.
3.9M sh · $76.93M
Blackrock, Inc.
3.0M sh · $67.24M
Millennium Management LLC
1.5M sh · $33.2M
Rtw Investments, LP
1.3M sh · $20.5M
Vanguard Group Inc
1.3M sh · $33.1M
Acadian Asset Management LLC
1.2M sh · $19.6M
Dimensional Fund Advisors LP
1.1M sh · $25.61M
Jacobs Levy Equity Management, Inc
782.1K sh · $16.05M
Jpmorgan Chase & Co
756.6K sh · $15.53M
D. E. Shaw & Co., Inc.
701.3K sh · $18.42M
Diametric Capital, LP
697.8K sh · $14.32M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book5
Overall Score3

INSIDER TRADES

★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
Hsieh Ming
Sale · 2.9K shares
2026-08-26
★
OFFICER: CFO AND TREASURER
Kim Paul
Sale · 1.2K shares
2026-08-26
★
OFFICER: PRESIDENT AND COO
Xie Jian
Sale · 1.2K shares
2026-08-27
★
OFFICER: CHIEF SCIENTIFIC OFFICER
Gao Hanlin
Sale · 939 shares
2026-08-27

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 1
1 GRADES IN THE LAST 12 MONTHS
Piper Sandler NEUTRAL

SECTORS PEERS

PEERPRICE
CDNA$49.79COMPARE
BFLY$8.43COMPARE
PSNL$17.07COMPARE
CSTL$33.50COMPARE
VALN$6.43COMPARE
ARVN$9.18COMPARE
PACB$1.40COMPARE
MYGN$3.16COMPARE